investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Development of Drugs that Target Prostate Cancer
William Figg
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Romano Danesi
University of Pisa
Pisa, Italy
William Figg
National Cancer Institute (NIH)
Rockville, United States
Related projects
James P Quigley
Role of Inflammatory Neutrophils and their Unique MMP-9 in Tumor Progression
Prostate
Pathology
Clare M Tempany
Enabling Technologies For MRI-Guided Prostate Interventions
Prostate
Pathology
Scott M Dehm
AR Gene Rearrangements and AR Signaling in Prostate Cancer
Prostate
Pathology
John J. Krolewski
An Androgen-Regulated Cytokine Network Controls Prostate Apoptosis.
Prostate
Pathology
Stefan Ambs
The Molecular Profile of Prostate Tumors in African-American Men
Prostate
Pathology
Clinton Kylie Matson
Exploiting the Genomic Programs Underlying AR-Independent Prostate Cancer
Prostate
Pathology
Zijie Sun
A New Regulator for Wnt/beta-catenin Signaling and Prostate Tumorigenesis
Prostate
Pathology
Mark D Adams
Impact of Mitochondrial Genome Variation on Extreme Prostate Cancer Disparities
Prostate
Pathology
Yan Xu
Role of Immune Cell OGR1 in Prostate Cancer Development and the Mechanisms Involved
Prostate
Pathology
